Premier Health of America Inc. (PHA.V)
CAD 0.14
(-9.68%)
CAD 0.14
(-9.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.86 Million CAD | 34.51% |
| 2022 | 5.61 Million CAD | -2.41% |
| 2021 | 5.9 Million CAD | 633.24% |
| 2020 | 804.92 Thousand CAD | 382.64% |
| 2019 | 868.4 Thousand CAD | -1454.2% |
| 2018 | -18.32 Thousand CAD | -103.95% |
| 2017 | 464.39 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 2.48 Million CAD | 620.9% |
| 2024 Q2 | 2.44 Million CAD | -19.19% |
| 2024 Q3 | 221 Thousand CAD | -346.28% |
| 2023 FY | - CAD | 34.51% |
| 2023 Q3 | 2.65 Million CAD | 41.16% |
| 2023 Q2 | 1.88 Million CAD | 57.89% |
| 2023 Q1 | 1.19 Million CAD | -46.41% |
| 2023 Q4 | 2.02 Million CAD | -23.76% |
| 2022 Q1 | 1.48 Million CAD | -12.16% |
| 2022 FY | - CAD | -2.41% |
| 2022 Q3 | 1.58 Million CAD | 239.69% |
| 2022 Q4 | 2.22 Million CAD | 40.13% |
| 2022 Q2 | 466.79 Thousand CAD | -68.58% |
| 2021 Q3 | 1.3 Million CAD | -17.22% |
| 2021 Q4 | 1.69 Million CAD | 29.12% |
| 2021 FY | - CAD | 633.24% |
| 2021 Q1 | 1.31 Million CAD | 111.9% |
| 2021 Q2 | 1.58 Million CAD | 19.98% |
| 2020 Q3 | 544.99 Thousand CAD | 177.54% |
| 2020 Q4 | 622.31 Thousand CAD | 14.19% |
| 2020 Q1 | -6597.00 CAD | 92.52% |
| 2020 Q2 | -702.83 Thousand CAD | -10553.78% |
| 2020 FY | - CAD | 382.64% |
| 2019 Q4 | -88.24 Thousand CAD | 24.29% |
| 2019 FY | - CAD | -1454.2% |
| 2019 Q3 | -116.55 Thousand CAD | -1615.28% |
| 2019 Q2 | -6795.00 CAD | -61.79% |
| 2019 Q1 | -4200.00 CAD | 76.92% |
| 2018 Q4 | -18.19 Thousand CAD | -43219.05% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q3 | -42.00 CAD | 70.63% |
| 2018 Q2 | -143.00 CAD | 0.0% |
| 2018 FY | - CAD | -103.95% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jack Nathan Medical Corp. | -4.95 Million CAD | 218.412% |